Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time this year on Tuesday, helped by strong demand for its cancer and rare diseases medicines, after third-quarter results beat estimates.

AstraZeneca AZN0.83%increase; green up pointing triangle raised its full-year guidance after third-quarter revenue and core earnings per share topped analysts’ expectations. The Anglo-Swedish pharmaceutical giant said Tuesday that it now expects its 2024 ...

Profits have risen at British pharmaceutical company AstraZeneca, leading to an improved forecast for the year as a whole. The multinational reported third-quarter profit of $1.43 billion compared to $1.

Drugmaker AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on Tuesday, helped by resilient demand for its cancer and rare diseases medicines. The London-listed company now expects 2024 revenue and core earnings per share to grow by high teens percentage,